#Bayer Ascensia Contour Diabetic Blood Glucose Test Strips | Explore Tumblr posts and blogs

diabeticcorner · 1 year ago

Text

Getting The Most Out Of Your Ascensia Bayer Contour Next Test Strips

Buy Ascensia Bayer Contour Next Test Strips For Glucose Care!! It stands for precision and reliability. This can aid you in monitoring your blood glucose levels accurately.

Use the Bayer Contour Blood Glucose 50 Test Strips and test your blood sugar level. They are available in a patented bottle design with built-in desiccant. This helps to keep them fresh for up to 6 months after opening. You can clearly view the level of the blood sample as they feature Sip-in Sampling technology.

In addition, these test strips don’t need coding. Consider Bayer’s contour blood glucose meter to use these test strips. They require as little as 0.6 microliter of blood sample for the test.

Harnessing The Full Potential Of Bayer Ascensia Contour Diabetic Blood Glucose Test Strips-

Firstly, follow the manufacturer's guidelines. This will help you to align the meter and strips properly for accurate readings. These Test Strips are particularly calibrated to give accurate results.

Secondly, a proper storage facility has to be there. These test strips can be affected by bad storage. You should store them in their original container, keep them away from extreme temperatures and direct sunlight.

Thirdly, clean your hands before using these test strips for your glucose monitoring. It can impact the accuracy of the readings. Also, follow the right method to apply the blood that will lead to the best outcome.

Fourthly, do not forget to check the accuracy of your meter and test strips. It ensures, if there are any discrepancies and if the readings are accurate. It aids to replace them on time if necessary.

Fifthly, always maintain the timing and consistency in testing. Diabetes patients should follow the recommended testing frequency and consult with your healthcare professional. Make sure you test your glucose level on time which will lead to better management. The condition of diabetes is critical when there is no care. With proper care and timing, you can manage your condition.

Sixthly, stay informed about the best Bayer Ascensia Contour Diabetic Blood Glucose Test Strips. Follow the user manual to properly use these test strips. Do not forget to consult with your doctor to get expert guidance recommendations. It will give you confidence.

In a nutshell, Ascensia Bayer test strips are an important tool to manage your diabetes efficiently. Applying these tips will maximize the potential ofAscensia Bayer test strips.

Ascensia Bayer Contour Next Test Strips, 50ct-

Patented bottle design with built-in desiccant

Visual verification: Easy viewing of sample fills.

Compatible with CONTOUR, CONTOUR USB and CONTOUR LINK meters

Tiny 0.6 µL blood sample

5-second test time

Contain:

1 box of 50 Contour Test Strips

This Item Is Only To Be Used With

Bayer Contour

Ascencia Contour

Item Is Not To Be Used With Following Meters:

Bayer Coutour Next EZ meter

A reliable and professional medical shop can cater to your test strip needs. Browse through www.diabeticcorner.com today and buy your Ascensia Bayer Contour Next Test Strips For Glucose Care. Diabetic Corner is a reputed shop to ensure customer satisfaction and competitive deals.

#Bayer Ascensia Contour Diabetic Blood Glucose Test Strips #Ascensia Bayer Contour Next Test Strips For Glucose Care

0 notes

healthcareblogsnews · 3 years ago

Text

Blood Glucose Test Strip Market Growth, Trends, Types Analysis & forecast to 2027

The blood glucose test strip market is presumed to garner USD 18.5 billion during the forecast period (2015-2020). The market is presumed to register 6.2 % CAGR owing to the increasing diabetic population, asserts Market Research Future (MRFR). Blood glucose test strip can be referred to as a small non-reusable plastic strip. It is a crucial component of blood glucose meters that helps to monitor and control diabetes.

Drivers and Constraints Impacting the Market

Blood glucose test strips are self-testing strips which let pre-diabetic and diabetic people track their blood glucose level on a regular basis without visiting a diagnostic laboratory or a clinic. With the growing diabetic population, the global market for blood glucose test strip is considered to foster during the assessment period. For instance, as per the International Diabetic Federation, around 415 million people had diabetes in 2015. The number is estimated to reach 642 million by the end of 2040. Moreover, technological advancements such as accuracy of the tests along with awareness among the people regarding diabetes are stimulating the market growth.

On the flip side, product recall owing to the inefficiency of devices such as intense competition resulting in pricing pressure and false glucose reading are some of the major factors considered to impede the global blood glucose test strip market in the coming years.

Global Blood Glucose Test Strip Market: Segmental Analysis

The blood glucose test strip market has been segmented on the basis of technology, distribution channel, and region.

By mode of technology, the global blood glucose test strip market has been segmented into optical, thin film electrochemical, self Monitoring blood glucose test strips and thick film electrochemical.

By mode of distribution channel, the global blood glucose test strip market has been segmented into retail pharmacy and hospital pharmacy. Among these, the hospital pharmacy is likely to dominate the global market and is anticipated to maintain its dominance over the assessment period. The growth is attributed to the increasing preference for self-care testing among the patients to monitor diabetes.

Regional Insights

Geographically, the global blood glucose test strip market span across regions namely, North America, Europe, Asia Pacific, and the Middle East and Africa.

Among all the regions, North America is presumed to lead the global blood glucose test strip market with $ 7.89 billion revenue. The growth is attributed to the extensive use of information technology coupled with high expenditure on healthcare. Moreover, the presence of major medical device manufacturers and high adoption of latest technologies are considered to stimulate the market during the review period.

Europe is estimated to hold the second position in the global market and is likely to maintain its dominance during the review period. High healthcare expenditure led by France and Germany is anticipated to drive the global market.

The Asia Pacific region is presumed to expand at a rapid pace owing to the presence of major regions such as India and China which are expected to lead the market due to unmet needs. This region is presumed to expand at 12.9 % CAGR owing to the growing number of diabetic population.

Industry Updates

January 2018: Ascensia Diabetes Care has recently announced the expansion of its strategic alliance with the Insulet Corporation which is a leader in tubeless insulin pump technology. The expansion follows the worldwide non-exclusive development agreement that Ascensia had announced in June 2017, to connect its CONTOUR NEXT ONE blood glucose monitoring system with Insulet's next-generation Omnipod System.

Competitive Dashboard

The major players operating the global market are Apex Biotechnology Corp, Shanghai MicroSense, ALL Medicus, Beijing Yicheng Electronics, Elektronika, Nipro Diagnostics, Bayer Diabetes Care, B. Braun, LifeScan, ACON Laboratories, Jiangsu Yuyue, HMD BioMedical Inc., TaiDoc, Betachek National Diagnostics, Roche Diagnostics, i-SENS, Universal Biosensors, Abbott, SANNUO, AgaMatrix Inc, and others.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York, New York 10013,

United States of America

+1 646 845 9312

Email: [email protected]

#Blood Glucose Test Strip Market #Blood Glucose Test Strip #Blood Glucose Test Strip Market Trends #Blood Glucose Test Strip Market News #Blood Glucose Test Strip Market Research

0 notes

market-research-future · 5 years ago

Text

Blood Glucose Test Strip Market Insights | Dynamics and Growth | Forecast To 2020

Market Research Future Published a Cooked Research Report on “Blood Glucose Test Strip Market Research Report- Global Forecast till 2020” Market Analysis, Scope, Stake, Progress and Trends.

Blood Glucose Test Strip Market Trends, Growth And Share Analysis By Technology (Thick Film Electrochemical, Thin Film Electrochemical, Optical) - Global Forecast Till 2020

Market Scenario

The blood glucose test strip market size is presumed to garner USD 18.5 billion during the forecast period (2015-2020). The market is presumed to register 6.2 % CAGR owing to the increasing diabetic population, asserts Market Research Future (MRFR). Blood glucose test strip can be referred to as a small non-reusable plastic strip. It is a crucial component of blood glucose meters that helps to monitor and control diabetes.

Drivers and Constraints Impacting the Market

Global Blood Glucose Test Strip Market: Segmental Analysis

The blood glucose test strip market has been segmented based on technology, distribution channel, and region.

By mode of technology, the global blood glucose test strip market has been segmented into optical, thin film electrochemical, and thick film electrochemical.

Geographically, the global blood glucose test strip market span across regions namely, North America, Europe, Asia Pacific, and the Middle East and Africa.

Industry Updates

Competitive Dashboard

The major players operating the global blood glucose test strip industry are Apex Biotechnology Corp, Shanghai MicroSense, ALL Medicus, Beijing Yicheng Electronics, Elektronika, Nipro Diagnostics, Bayer Diabetes Care, B. Braun, LifeScan, ACON Laboratories, Jiangsu Yuyue, HMD BioMedical Inc., TaiDoc, Betachek National Diagnostics, Roche Diagnostics, i-SENS, Universal Biosensors, Abbott, SANNUO, AgaMatrix Inc, and others.

Brows More Medical Devices Related Market Research Reports:

Clinical Reference Laboratory Market Share Analysis, Size | Industry Trends, 2027

Facial Injectable Market Trends Analysis, Share | Size and Applications, 2023

Healthcare BPO Market Share, Size Analysis | Industry Trends, 2023

About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact

Market Research Future

Office No. 528,

Amanora Chambers Magarpatta Road,

Hadapsar,

Pune - 411028

Maharashtra,

India

+1 646 845 9312

Email: [email protected]

0 notes

saojip13 · 5 years ago

Text

Diabetes Care Devices Market 2019 Players: Abbott Laboratories, Dexcom Inc., Merck & Co, etc

Diabetes is the most widespread metabolic disorder in which patient body is unable to use the glucose due to the lack of Insulin. The major cause of diabetes is insulin deficiency secreted by beta cells of the islet of Langerhans of the pancreas. The other factors include genetically inheritance, changing lifestyle, and unhealthy diets can also cause diabetes. Diabetes further has severe effects on the body like internal damaging of organs and hence require regular monitoring and controlled level of glucose levels in the body. Diabetes care devices are user-friendly and can be operated by patients themselves; they monitor the blood glucose level and help patients to control diabetes. There are two different type of diabetes, caused due to decreasing ability of the pancreas to produce the insulin and another is due to lack of response to the insulin. Diabetes is a chronic disease and the people suffering from diabetes needs to monitor blood glucose throughout their life.

Get a Sample Copy of this Report @ https://www.alexareports.com/report-sample/170627

Global diabetes care devices market is growing at a significant rate due to the increase in the incidence of diabetes, especially in adults. The key drivers for the growth of global diabetes care devices market are rise in innovative technologies, minimally or non-invasive products and increasing diabetic population boosting the growth of global diabetes care devices market. Similarly, availability of devices, that are faster, effective, safer, and user-friendly are the key factors fuel the growth of the global diabetes care devices market over the forecast period. Apart from this, government and private investment in research and development, and low diagnostic rates might fuel the growth of global diabetes care devices market. However, the high cost of new devices, lack of awareness, stringent regulatory obligations, and disparity in reimbursements are some the factors that are constraining the growth of global diabetes care device market.

Global diabetes care devices market has been segmented on the basis of product type, and distribution channel

Based on product type, global diabetes care devices market has been segmented into the following:

Blood glucose monitoring devices Self-monitoring blood glucose meters Continuous glucose meters Consumables Others

Based on distribution channel, global diabetes care devices market has been segmented into the following:

Hospital pharmacy Retail Pharmacy Online Pharmacy Others

Grab amazing discount here @ https://www.alexareports.com/check-discount/170627

Globally, diabetes is the fourth leading cause of death. According to the International Diabetes Federation (IDF), seven Mn people are added every year to the pool of 246 Mn diabetics, which is projected to increase approximately 438 Mn by 2030. Moreover, about 3.8 Mn people die each year from diabetes. The global diabetes care devices market is highly fragmented with the presence of several large and small vendors, due to which it witnesses an intensely competitive environment. For the development of new products, and enhance the competitiveness, most vendors partnering with other vendors in the global diabetes care devices market. For instance, in June 2016, Ascensia Diabetes Care partnered with Medtronic for developing and marketing diabetes management solutions. Furthermore, to develop and market test strips and blood glucose meters, vendors are also undertaking strategic alliances due to which the market presents a significant opportunity for new players in the global diabetes care devices market. In 2000, Minimed has launched the Continuous Glucose Monitoring System in the global diabetes care devices market which measures and store glucose values for 3 days. Further, the device is developed to store the results up to 6 or 7 days and helps to see data in the real time. For instance, Medtronic (Enlite, Guardian Realtime), Abbott (Freestyle Navigator II), and Dexcom’s (G4 Platinum)

Geographically, the diabetes care devices market has been segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America dominates the markets followed by Europe and Asia-Pacific. North America garners significant market share due to the growing diabetic population. According to American Diabetes Association, the prevalence of diabetes in 2015 is 30.3 Mn or 9.4% in U.S., availability of skilled professionals, and reimbursement for the diabetes care devices are the major factors contributing to the growth of the global diabetes care devices market in North America. Europe is the second largest region for global diabetes care devices market in the world due to the rapidly aging population and drastic changes in lifestyle. Asia-Pacific region is major market for global diabetes care devices due to the large patient pool, and rising diabetes incidence in the region. According to the International Diabetes Federation (IDF), China has the largest number of diabetic patients with around 96.2 Mn and India has around 66.8 Mn diabetic patients, which represents approximately 45% of the global diabetic population. Aforementioned factors help to boost diabetes care devices market in Asia-Pacific region.

Some of the players in global diabetes care devices market are Abbott Laboratories (Abbott, Inc.) (U.S.), Dexcom Inc. (U.S.), Johnson & Johnson Services Inc.(U.S.), Merck & Co, Inc. (U.S.), F. Hoffman-La Roche (Switzerland), Becton-Dickinson and Company (U.S.), Novo Nordisk A/S (Denmark), Bayer AG (Germany), Medtronic plc. (Ireland), Terumo Corporation, Inc. (Japan), Ascensia Diabetes Care (U.S.) Panasonic Healthcare Holdings Co. Ltd. (Japan) and Eli Lilly and Company (U.S.) to name a few.

To Enquire About This Comprehensive Report @ https://www.alexareports.com/send-an-enquiry/170627

In December 2015, Novo Nordisk and IBM Watson Health partnered to create diabetes solutions built on the Watson Health Cloud

In June 2015, Panasonic Healthcare acquired Bayer diabetes unit’s Contour portfolio of blood glucose monitoring meters and strips

Report Outline:

The report provides granular level information about the market size, regional market share and forecast from 2019-2025 The report covers in-detail insights about the competitor’s overview, key findings and their key strategies The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry The report tracks recent innovations, key developments and startup’s details that are working in the industry The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

Details of the market study:

Historical Data: 2014 & 2017

Base Year: 2018

Forecasts: 2019-2025

CAGR: 2019-2025

Market trend analysis in terms of drivers, restraints and opportunities

Industry analysis using Porter’s, PESTEL and SWOT

Market estimates and forecasts available for the following regions and countries:

Market players analysis in terms of company’s overview, financial performance, product/service benchmarking and strategic initiatives taken up by them

North America (U.S. & Canada)

Europe (UK & Germany)

Asia Pacific (Japan & China)

Latin America (Brazil, Mexico)

MEA (South Africa)

#Diabetes Care Devices Market

0 notes

healthcarebiz · 8 years ago

Text

Scientific Studies Addressing BGMS and CGM Accuracy Presented at the American Diabetes Association's 77th Scientific Sessions

SAN DIEGO, June 12, 2017 /PRNewswire/ -- This week at the American Diabetes Association 77th Scientific Sessions, data were presented from three studies that assessed the accuracy and analytical performance of blood glucose monitoring systems (BGMS) and continuous glucose monitoring (CGM) systems. Posters from two investigator initiated studies presented the accuracy data of various BGMS, while another poster, presented by Ascensia, described a new method for evaluating the analytical performance of CGM systems. The American Diabetes Association's 77th Scientific Sessions are taking place in San Diego, California from June 9-13, 2017.

The lead investigator for the above mentioned investigator initiated studies, Dr. Guido Freckmann (Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH), presented two posters (117-LB and 915-P). One of these posters presented an evaluation of five BGMSs, including the CONTOUR®NEXT ONE system, by applying the ISO 15197:2013 accuracy criteria (95% or more test results must fall within ±15 mg/dL or ±15% at glucose concentrations <100 mg/dL or ≥ 100 mg/dL respectively, and 99% or more of test results must fall within Zones A and B of the Consensus Error Grid for Type 1 diabetes).[1] The other poster presented an evaluation of four BGMSs, including the CONTOUR®PLUS ONE system, using the same ISO 15197:2013 accuracy criteria.[2] In both studies the data were obtained from 100 people with diabetes who had not used their assigned BGMS before. In each study, the subjects performed their own measurements and their readings were compared to a reference method. In these studies, both the CONTOUR®NEXT ONE and CONTOUR®PLUS ONE systems were shown to be highly accurate in the hands of lay-users.

In the study that included the CONTOUR®NEXT ONE BGMS, four of the five BGMS fulfilled the user performance criteria of ISO 15197:2013, but differences were observed in the percentages of results within the accuracy limit. 100% of results for the CONTOUR®NEXT ONE BGMS in the hands of lay-users fell within the accepted ISO 15197:2013 accuracy criteria. The percentages of test results that fell within these accuracy criteria for the other systems in the study were 96% for the Accu-Chek® Aviva Connect, 95% for the FreeStyle® Freedom Lite, 95% for the GlucoMen® Areo and 93% for the OneTouch® Verio. None of the results provided by each system was found to be clinically unacceptable.

In the study that included the CONTOUR®PLUS ONE BGMS, three of the four BGMS fulfilled the user performance criteria of ISO 15197:2013. 100% of results for the CONTOUR®PLUS ONE BGMS in the hands of lay-users fell within the accepted ISO 15197:2013 accuracy criteria and 99% were within the stricter criteria of ±10 mg/dL and ±10% for glucose concentrations <100 mg/dL and ≥100 mg/dL, respectively. The percentages of test results that fell within the ISO 15197:2013 accuracy criteria for the other systems in the study were 96% for the Accu-Chek® Performa Connect, 98% for the FreeStyle® Optium Neo and 92% OneTouch® Select Plus. All results provided by all systems were found to be clinically acceptable.

Dr. Freckmann noted that "The accuracy of blood glucose monitoring systems continues to be critical for people with diabetes. They must be able to trust the readings they receive to enable them to make the correct decisions for the management of their condition. To achieve comparable performance in the hands of people with diabetes and healthcare professionals, blood glucose monitoring systems should be easy to use and resistant to errors."

Funding for the investigator initiated studies and support for writing were provided by Ascensia Diabetes Care Germany GmbH.

As for the methodological study presented by Pardo et al.[3], this poster showed that an error probability calculation, facilitated by the gamma distribution model, may be used in addition to MARD to provide a more informative tool for assessing the accuracy and analytical performance of CGM systems.

The CONTOUR® NEXT ONE system is available in the U.S. and various European countries where the CONTOUR®NEXT test strips are available. The CONTOUR®PLUS ONE system has been launched in selected countries where the CONTOUR®PLUS test strips are available. Both systems are designed to connect via Bluetooth® technology to the CONTOUR™ DIABETES app, which is available for download from the Apple App Store (iOS) and Google Play (Android).

About Ascensia Diabetes Care

Ascensia Diabetes Care is a global specialist diabetes care company, dedicated to helping people living with diabetes. Our mission is to empower people living with diabetes through innovative solutions that simplify and improve their lives. We use our innovation and specialist expertise in diabetes to develop high quality solutions and tools that make a positive, daily difference for people with diabetes.

Home to the world renowned CONTOUR® portfolio of blood glucose monitoring systems, our products combine advanced technology with user-friendly functionality that help people with diabetes to manage their condition. We are committed to continued research, innovation and development of new products and solutions. As a trusted partner in the diabetes community, we collaborate closely with healthcare professionals and other partners to ensure our products meet the highest standards of accuracy, precision and reliability, and that we conduct our business compliantly and with integrity.

Ascensia Diabetes Care was established in 2016 through the sale of Bayer Diabetes Care to Panasonic Healthcare Holdings Co., Ltd. Ascensia Diabetes Care products are sold in more than 125 countries. Ascensia Diabetes Care has around 1,700 employees and operations in 33 countries.

For further information, please visit the Ascensia Diabetes Care website at: http://www.ascensia.com.

© 2016 Ascensia Diabetes Care. Ascensia and Contour are trademarks and/or registered trademarks of Ascensia Diabetes Care. The Bluetooth word mark and logos are registered trademarks owned by Bluetooth SIG, Inc., and any use of such marks herein is under license. All product names and trademarks are the property of their respective owners.

1. Freckmann, G. et al. (2017, June) Performance evaluation of five blood glucose monitoring systems in the hands of intended lay-users following ISO 15197:2013. Poster presented at the American Diabetes Association's 77th Scientific Sessions San Diego, CA.

2. Freckmann, G. et al. (2017, June) Performance evaluation of four blood glucose monitoring systems in the hands of intended lay-users following ISO 15197:2013. Poster presented at the American Diabetes Association's 77th Scientific Sessions San Diego, CA.

3. Pardo S. et al. (2017, June) A New Method to Evaluate Analytic Performance of CGM Devices. Poster presented at the American Diabetes Association's 77th Scientific Sessions San Diego, CA.

For more information, please contact: Joseph Delahunty, VP, Global Head of Communications Ascensia Diabetes Care E-mail: [email protected] Phone: +41-61-560-8760

Read this news on PR Newswire Asia website: Scientific Studies Addressing BGMS and CGM Accuracy Presented at the American Diabetes Association's 77th Scientific Sessions

#Healthcare

0 notes

topbarhealth · 8 years ago

Text

New Post has been published on Top Bargain Health & Wellness

New Post has been published on http://topbargainhealth.com/2017/03/26/bayer-contour-diabetic-test-strips-pack-of-50/

Bayer Contour Diabetic Test Strips (Pack of 50)

Formerly Ascensia Microfill. The Ascensia Contour Blood Glucose test strips are designed for use with the Ascensia Contour Blood Glucose Meter and are easy to use, no coding required. This package contains 50 strips.

#Bayer #Bayer Contour Diabetic Test Strips (Pack of 50)#KL-JKL7-BRCC.MISSING

0 notes

type2diabetestreatments-blog · 8 years ago

Text

Test Driving Ascensia's New Contour Next ONE Meter

New Post has been published on http://type2diabetestreatment.net/diabetes-mellitus/test-driving-ascensias-new-contour-next-one-meter/

Test Driving Ascensia's New Contour Next ONE Meter

It's often the little details that translate to the biggest benefits when it comes to taking care of your diabetes.

That was top of mind for me after trying out the new Ascensia Contour Next ONE meter, the latest in the line of Contour meters from the company formerly known as Bayer. Approved by the FDA in November 2016, this Contour Next ONE meter sports a next-generation design with subtle differences from its predecessors, and it's the first app-enabled meter Ascensia has brought our way in the Contour line.

I must say, I'm impressed with Ascensia of late, for what they've produced and the innovations in their pipeline that include partnering with Glooko for better data-sharing access on multiple platforms.

Let's dig into this new meter itself...

Meeting the New Contour Next ONE

The new Next ONE model is an upgrade of the Contour Next USB meter, which was discontinued as of Dec. 31, 2016. I'd been using that meter for several years, including a version that links wirelessly to my former Medtronic insulin pump. I've loved the meter for its finger-sized portability, and now that I'm disconnected from an insulin pump and on Multiple Daily Dosing instead, I no longer need the linking capability. Fortunately, my test strip supply is fully stocked and this new meter uses the same Contour Next test strips, so it doesn't require a new prescription, making for an easy transition.

Sleeker, Slimmer: While the form factor is mostly unchanged, it is a bit thinner and sleeker in design. The earlier generation Contour Next meter had a button on the top side of the meter to turn it on and off, plus three buttons on the meter face allowing you to select and scroll through meter menus. Now, the Contour Next ONE has eliminated all of those buttons except for a single round circle 'OK' button with an up and down choice.

New Screen: Not sure if you consider this an upgrade or a downgrade honestly, but the previous color LED screen is now gone and in its place is a basic black and white LED with icons to indicate your glucose log or settings. There isn't a built in backlight, though you really don't need it since the screen does light up enough to use efficiently even in the dark.

Watch Battery: Ascensia took away the rechargeable USB and instead is now using a round watch battery. I have mixed feelings on this, as I do like the ability to plug-and-charge my meter wherever I may be, with no need to run out and buy these less-common batteries. There is a micro-USB included, but it doesn't charge the meter. It's designed purely to plug into a computer to download data and use the software; unfortunately, you have to buy the cable separately because it's not included in the box.

(Hidden!) Port Light: Yes, there is a port light you can use to illuminate the spot where the test strip is inserted. But you might not know it at first, if you just looked at the meter or even if you read every single piece of marketing material Ascensia includes -- because for some reason, the port light is not described as a feature. Seriously, even reading the manual cover-to-cover, you'll never see a mention of the fact that you can actually make the port light work for up to 40 seconds before turning the meter on. For the first few weeks I used this meter, I assumed it had no port light aside from the two-second flash it gives when the meter is turned on. I actually used my Dexcom receiver to light up the meter so I could insert a strip in a darkened room. Then just by happenstance, I double-tapped the round OK button and discovered this hidden gem! Seriously, Ascensia: this is a huge factor for many PWDs (people with diabetes), especially those of us who enjoy movie theaters or regularly test in the middle of the night.

Target Lights: A new feature on this meter embraces the industry trend of attempting to help PWDs answer the key question, "What do my blood glucose numbers actually mean?" -- that's common among the newly-diagnosed and many with type 2. Ascensia is using what it calls Target Lights, which light up in green/ yellow/ red post-result to indicate whether you are "In Range," "Low" or "High."

Second-Chance Sampling: This is a small difference, but now you have 60 seconds instead of 30 seconds to apply a second drop of blood to the same strip, in case the first attempt wasn't large enough. Handy for those of us who sometimes struggle to get "bleeders" after a fingerstick, and need to take extra time to redo the sample.

Accuracy: Although the minutiae of glucose meter accuracy may no longer be a hot topic these days, we firmly believe that it's still very important. And this new Contour Next ONE meter is the most accurate product Ascensia has produced to date. New data presented at the European ATTD conference in February shows that this Ascensia meter meets the FDA's tightened accuracy requirements of 95% within 8.4 mg/dL of reference results, whether the test is above or below 100.

The Contour Next ONE App

With the launch of this new meter, Ascensia joins the #DData world by offering its Contour mobile app to display data on both iOS and Android smart-devices. Being an Android guy myself, I truly appreciate that this is available beyond just iPhones at the time of launch.

The Next ONE meter has built-in Bluetooth and syncs data with the mobile app, though I did find that frequently the meter didn't automatically sync like it's supposed to but encountered connectivity issues. It was more annoying than anything, and I've heard from others using this new meter that it's not just me (and to be fair, the Dexcom app often has the same issues).

From a UI perspective, the Contour app is very user-friendly and easy to navigate. It presents you with all the features you'd expect in a mobile meter app in 2017: logbook, averages, trend-tracking and meal information, photo uploading and data-sharing.

You can find latest readings on the home screen, with the 'My Readings' menu representing the traditional logbook, and that three-day overview graph is always visible when you're scrolling through the readings. You can easily peruse averages over the past week to three months, and by tilting the phone to horizontal orientation, you can also get a standard day's view or break it down for specific data over 3-30 days, a customized time block or by meals or time of day. Very nice!

In particular, I like the ability to add photos within the app -- whether it's my morning Greek yogurt with blueberries that rings in at roughly 16g carbs, or a picture of the meter next to my Dexcom CGM.

Using what it calls a 'Smart Testing' feature, this new meter also allows you to set a customized alert to check your glucose during the day, remind yourself of upcoming doctor visits, or other particulars you might want to be reminded of.

Of course, there is the ability to share diabetes data through the app with your healthcare professional or anyone else you might want to share it with. The app also gives you a prompt during a critical Low to alert an emergency contact, helping to assure that you can get assistance if needed.

In addition to this app, users can look forward to the upcoming integration with the Glooko data platform, set to be rolled out later this year, that will make Contour Next ONE data directly accessible through Glooko's mobile app and clinical products.

Final Verdict and Availability

The meter itself is going for a suggested retail cost of $19.99, while the strips are supposedly priced at 83 cents per strip, or $41.55 for a 50-count box (though most found in retail pharmacies run just over $1 per strip).

Ascensia is currently launching the Contour Next ONE meter throughout the US, coming soon to mainstream chains like Walgreens, Target and CVS. The ETA for most distributors is the end of March, we're told. Meanwhile, you can purchase the meter directly from the Ascensia customer store online and other online suppliers.

Overall, it's a nice little meter. I personally miss the color screen of the previous-generation Contour Next USB meter, and since I'm a Dexcom CGM customer who uses the mySugr app for diabetes data-tracking, the Contour Next app didn't knock my socks off enough to change up my tools.

Still, I think it's a great addition for those who might want and need an aesthetic, accurate little meter with some strong data-tracking tools.

Disclaimer: Content created by the Diabetes Mine team. For more details click here.

Disclaimer

This content is created for Diabetes Mine, a consumer health blog focused on the diabetes community. The content is not medically reviewed and doesn't adhere to Healthline's editorial guidelines. For more information about Healthline's partnership with Diabetes Mine, please click here.

Type 2 Diabetes Treatment Type 2 Diabetes Diet Diabetes Destroyer Reviews Original Article

0 notes

diabeticcorner · 1 year ago

Text

Benefits Of Bayer Ascensia Contour Diabetic Blood Glucose Test Strips

Shop for Bayer Ascensia Contour Diabetic Blood Glucose Test Strips online! This is one of the most advanced test strips that take care of your glucose level effectively.

Undoubtedly, managing your glucose levels is essential if you are a diabetic patient. Different types of test strips are offered by several brands. Choosing the best and innovative solutions for diabetes care can make a huge difference. This is where reliable Ascensia Bayer Contour Next Test Strips For Glucose Care stand out. It allows you to manage your glucose levels easily and accurately.

Key Highlights Of Bayer Ascensia Contour Diabetic Blood Glucose Test Strips-

Accurate Glucose Monitoring- The most unique advantage of using these test strips is their precision in glucose monitoring. They involve advanced technology to ensure accurate results. The Contour Next Test Strips reduce the chance of errors and offer reliable readings which are important for effective diabetes management.

User-Friendly Design- The Ascensia Bayer test strips come with a user-friendly design. Anyone can easily use these test strips. It features an easy application process. It needs a small blood sample to deliver accurate results quickly. They can cater to diverse user preferences.

Quality Performance- These test strips perform well and ensure fast and reliable results. It allows you to make the right decision about your glucose management. They don’t need coding and are designed for use with Bayer’s Contour Blood Glucose meter.

Enhanced Convenience- When it comes to managing your diabetes, convenience plays a key role. They are compact and portable so easy to carry anywhere. They come in a patented bottle design with built-in desiccant, which helps to keep them fresh for up to six months after opening. These Ascensia contour test strips make it easy to view the level of the blood sample as they feature Sip-in Sampling technology.

Technology Advancements- They use advanced technology that improves the standard of glucose monitoring. They ensure accuracy and reliability in every use. They are Compatible with CONTOUR, CONTOUR USB and CONTOUR LINK meters.

In a nutshell, these Ascensia contour test strips are an imperative tool for managing your glucose levels effectively. Look for a reliable medical supplier that ensures quality products.

Looking for Bayer Ascensia Contour Diabetic Blood Glucose Test Strips? Diabetic Corner is your right stop. Test your blood sugar level with ease using the Bayer Contour Blood Glucose 50 Test Strips. Available only at $16.99! Visit our website today!

#Bayer Ascensia Contour Diabetic Blood Glucose Test Strips #Ascensia Bayer Contour Next Test Strips For Glucose Care

0 notes

diabeticcorner · 2 years ago

Audio

Do you need Ascensia Bayer Contour Next Test Strips for Glucose Care? You can count on us. Our Bayer Ascensia Contour Diabetic Blood Glucose Test Strips will help you test your blood sugar level with ease.

#Bayer Ascensia Contour Test Strips #Bayer Ascensia Contour Diabetic Blood Glucose Test Strips

0 notes

diabeticcorner · 9 months ago

Text

Figuring Out What Affects The Accuracy of Test Strips.

Accurate testing is incredibly crucial for competing with diabetes and reliable blood glucose readings significantly depend on it. In this paragraph, we will look into whether blood glucose testing is determined. Analyzing the elements that lead to the precision of Clever Choice test strips is the first step towards ensuring that people living with diabetes have consistent sugar level readings. The test strips represent an important component in tracking blood glucose levels. In this article, we will look into whether blood glucose testing is determined.

How Blood Glucose Accuracy is Determined:

The accuracy of glucose monitoring is assessed by conducting FDA-approved standardized tests that are strictly monitored. These tests check the functionality of glucometers, and test strips and classify their performance in different conditions and against certain accuracy criteria. Get a quality one like Ascensia Bayer Contour Next Test Strips For Glucose Care and get done with your blood glucose test.

6 Factors That Can Affect Glucose Meter Accuracy:

Quality of Test Strips: Test strip quality and manufacturing standards used with the glucose meter have a notable impact on accuracy.

Environmental Conditions: Climatic conditions that are on both ends of the scale (hot and icy) and humidity can negatively impact the glucose meter performance.

User Technique: Wrong practices of the glucose meter have resulted in error readings and some of the practices include wrong sample size of blood, wrong handling of test strips, and wrong calibration of the meter.

Interference from Substances: For instance, a single high dose of some substances, such as vitamin C or medications containing certain compounds, can lead to interference with the glucose meter readings.

Meter Calibration: The diabetics should remember that glucose meters require regular calibration to keep their accuracy intact.

Meter Maintenance: Regular maintenance of the glucose meter, including cleaning and battery replacement.

Why choose Clever Choice Pharmacist Choice Voice 300 Test Strips?

Pharmacist Choice is auto-coding blood glucose strips from Clever Choice. It is a 300-ct package.

Accuracy: These test trips help in giving an accurate result, the glucose reading which is very vital when it comes to good diabetes management.

Ease of Use: The strip is designed to be easy to handle and use with glucose meters, the strips are conveniently integrated into our daily routine.

Quick Results: Giving rapid result data, in this case, blood glucose sugar levels efficiently monitoring.

Cost-Effective: Pharmacists Choice 300 units Strips can be the cheapest choice if compared with other competitors if purchased in large quantities.

Conclusion

In general, although meters and test strips are critical in curbing diabetes and its effects, their precision should not be compromised. Thoroughly grasping the elements determining accuracy and the verified devices, definitely the Ascensia Bayer Contour Next Test Strips For Glucose Care can overall really aid in improving reading reliability. Get it today!

#Clever Choice Test Strips #Ascensia Bayer Contour Next Test Strips For Glucose Care

0 notes

diabeticcorner · 1 year ago

Text

Order the best-quality Bayer Ascensia Contour Test Strips online from Diabetic Corner. The test can be done at home and requires only a 0.6 uL blood sample. It produces fast, highly accurate results in 1 to 2 seconds and eliminates errors due to user miscoding. Don’t go anywhere!

#Bayer Ascensia Contour Test Strips

0 notes

market-research-future · 5 years ago

Text

Blood Glucose Test Strip Market Share, Size, Growth and Dynamics | Forecast To 2020

Blood Glucose Test Strip Market Overview by Share, Size, SWOT Analysis, Segmentation, Emerging Trends, Future Outlook, Applications, Insights, Profile, key Players, Future Outlook, PESTEL analysis with Regional Insights of North America, Asia-Pacific, Europe, and the Middle East & Africa, Forecast To 2020

The Blood Glucose Test Strip Market is presumed to garner USD 18.5 billion during the forecast period (2015-2020). The market is presumed to register 6.2 % CAGR owing to the increasing diabetic population, asserts Market Research Future (MRFR). Blood glucose test strip can be referred to as a small non-reusable plastic strip. It is a crucial component of blood glucose meters that helps to monitor and control diabetes.

Drivers and Constraints Impacting the Market

Request Free Sample Report at: https://www.marketresearchfuture.com/sample_request/976

Global Blood Glucose Test Strip Market: Segmental Analysis

The blood glucose test strip market has been segmented on the basis of technology, distribution channel, and region.

By mode of technology, the global blood glucose test strip market has been segmented into optical, thin film electrochemical, and thick film electrochemical.

Regional Insights

Geographically, the global blood glucose test strip market span across regions namely, North America, Europe, Asia Pacific, and the Middle East and Africa.

Browse Full Research Report at: https://www.marketresearchfuture.com/reports/global-blood-glucose-test-strip-market-976

Industry Updates

Ascensia Diabetes Care has recently announced the expansion of its strategic alliance with the Insulet Corporation which is a leader in tubeless insulin pump technology. The expansion follows the worldwide non-exclusive development agreement that Ascensia had announced, to connect its CONTOUR NEXT ONE blood glucose monitoring system with Insulet's next-generation Omnipod System.

Competitive Dashboard

Brows More Healthcare Related Research Reports:

Global Test Strip Market Research Report- Forecast to 2021

Insulin Pump Market Research Report- Global Forecast To 2022

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: [email protected]

0 notes

healthcarebiz · 8 years ago

Text

Ascensia Diabetes Care Announces Strategic Alliance with Insulet Corporation to Connect CONTOUR(R)NEXT ONE BGMS and Omnipod Dash(TM) PDM

BASEL, Switzerland, June 8, 2017 /PRNewswire/ -- Ascensia Diabetes Care today announced it has entered into a strategic alliance by signing a development agreement with Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (the Omnipod System). Under the terms of this agreement, the Ascensia CONTOUR®NEXT ONE blood glucose monitoring system (BGMS) will connect to Insulet's next-generation Omnipod System (the Omnipod Dash™ System), which is currently in development. Seamlessly connecting the CONTOUR®NEXT ONE BGMS and the Omnipod Dash™ System will provide people living with diabetes with an innovative continuous insulin delivery system to manage their diabetes, powered by remarkably accurate blood glucose readings.

The CONTOUR®NEXT ONE BGMS will pair, via Bluetooth Low Energy (BLE), with the Omnipod Dash™ Personal Diabetes Manager (Omnipod Dash™ PDM) to automatically transmit a person's blood glucose readings directly into the system. These readings will be used by the Omnipod Dash™ PDM to calculate insulin dosing and support highly accurate delivery of insulin for people living with diabetes. Under the terms of this worldwide non-exclusive agreement, Insulet will develop and seek marketing clearance for the Omnipod Dash™ PDM, with collaboration from Ascensia Diabetes Care who will provide the CONTOUR®NEXT ONE meter and CONTOUR®NEXT test strips.

"We are delighted to enter into this agreement that brings together these innovative technologies from both companies," said Michael Kloss, CEO, Ascensia Diabetes Care. "The integration of our BGM system with Insulet's tubeless insulin pump system has significant potential to help people take control of their lives and their diabetes. We are pleased that our highly accurate system has been chosen to provide the critical blood glucose data that will be used by the Omnipod Dash™ PDM to calculate insulin dosing for patients."

"We are thrilled to partner with Ascensia as part of our development efforts on our next-generation Omnipod Dash platform, which will allow Insulet to maintain its competitive edge with truly innovative and differentiated products," said Shacey Petrovic, President and Chief Operating Officer.

The CONTOUR®NEXT ONE BGMS received 510(k) clearance from the FDA in November 2016 and has been shown to meet the stricter accuracy requirements of the FDA Over-the-Counter BGMS Guidance that was recently issued in 2016. In a clinical study, 95% of blood glucose results obtained with the CONTOUR®NEXT ONE BGMS were within 8.4 mg/dL (0.5 mmol/L) or 8.4% of the reference result for subject fingertip tests.[1]

Michael added, "This alliance is the next step in our goal of providing integrated solutions for people living with diabetes. We believe that integrated diabetes management is the future and are happy to work with partners that will help us to achieve this goal together. One aspect of this is pump therapy, where we have established ourselves as the partner of choice for blood glucose monitoring in the pump sector. We are excited that Insulet recognizes the value the CONTOUR®NEXT ONE BGMS can bring to users of Omnipod's product platform."

Notes for Editors

About Ascensia Diabetes Care

For further information, please visit the Ascensia Diabetes Care website at: http://www.ascensia.com.

About Insulet Corporation

Insulet Corporation (NASDAQ: PODD) is an innovative medical device company dedicated to making the lives of people with diabetes easier. Through its Omnipod Insulin Management System, Insulet seeks to expand the use of insulin pump therapy among people with insulin-dependent diabetes. The Omnipod is a revolutionary and easy-to-use tubeless insulin pump that provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet's Delivery Systems business also partners with global pharmaceutical and biotechnology companies to adapt the Omnipod technology platform for the delivery of subcutaneous drugs across multiple therapeutic areas. Founded in 2000, Insulet Corporation is based in Billerica, Massachusetts. For more information, please visit: http://ift.tt/1nJvtB0.

© 2017 Ascensia Diabetes Care. Ascensia and Contour are trademarks and/or registered trademarks of Ascensia Diabetes Care. All other trademarks are the property of their respective owners. The use of third party trademarks does not constitute an endorsement or imply a relationship or other affiliation.

References

1. Christiansen et al. Poster presented at the 15th Annual Meeting of the Diabetes Technology Society, October 22-24, 2015, Bethesda, Maryland.

For further information, please contact: Joseph Delahunty Ascensia Diabetes Care [email protected] Tel: +41-61-560-8760

Read this news on PR Newswire Asia website: Ascensia Diabetes Care Announces Strategic Alliance with Insulet Corporation to Connect CONTOUR(R)NEXT ONE BGMS and Omnipod Dash(TM) PDM

#Healthcare

0 notes